Figure S8 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts

Bomiao Hu, Marc Wiesehöfer,Fernando J. de Miguel,Zongzhi Liu, Lok-Hei Chan,Jungmin Choi,Mary Ann Melnick, Anna Arnal Estape,Zenta Walther, Dejian Zhao,Francesc Lopez-Giraldez,Anna Wurtz,Guoping Cai, Rong Fan,Scott Gettinger,Andrew Xiao,Qin Yan,Robert Homer,Don X. Nguyen,Katerina Politi

crossref（2024）

引用 0|浏览5

暂无评分

摘要

Changes in chromatin accessibility in HCC827 and PC9 cells upon ASCL1 expression. Global changes in chromatin accessibility in mutant EGFR lung cancer cell lines following ASCL1 overexpression and osimertinib treatment.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Figure S8 from ASCL1 Drives Tolerance to Osimertinib in &lt;i&gt;EGFR&lt;/i&gt; Mutant Lung Cancer in Permissive Cellular Contexts

Figure S8 from ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular Contexts